GAITHERSBURG, Md., May 27, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. ALT, a clinical-stage biopharmaceutical company, today announced that members of the management team will present during a fireside chat at the 2021 Jefferies Virtual Healthcare Conference, being held June 1 - 4, 2021.
Details on the Jefferies fireside chat presentation are as follows:
| Title: | 2021 Jefferies Virtual Healthcare Conference | ||
| Presenters: | Vipin Garg, Ph.D., Chief Executive Officer | ||
| Scot Roberts, Ph.D., Chief Scientific Officer | |||
| Scott Harris, M.D., Chief Medical Officer | |||
| Date/Time: | Wednesday, June 2, 2021 at 11:30 am ET |
A webcast link to the fireside chat presentation will be accessible on the Events section of the Altimmune website.
About Altimmune
Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™). For more information on Altimmune, please visit www.altimmune.com.
| Investor & Media Contacts: | ||
| Will Brown | Stacey Jurchison | |
| Chief Financial Officer | Sr. Dir, Investor Relations | |
| Phone: 240-654-1450 | Phone : 410-474-8200 | |
| wbrown@altimmune.com | sjurchison@altimmune.com |
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
